Gilead Sciences breaks ground on new manufacturing and technical development site in US
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
He has been associated with the Zydus Group since 2009
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha
The U.S. FDA issued a Form 483 with five observations
Subscribe To Our Newsletter & Stay Updated